Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Zoller

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Blood Purification|November 7, 2024
Albumin and Platelet Loss during the Application of CytoSorb® in Critically Ill Patients: A post hoc Analysis of the Cyto-SOLVE TrialClara Isabell Brozat, Michael Zoller, Sandra Frank, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2016
Predictors of Inadequate Linezolid Concentrations after Standard Dosing in Critically Ill PatientsMax Taubert, Michael Zoller, Barbara Maier, et al.
Journal of Critical Care|March 27, 2014
Influence of abdominal obesity on multiorgan dysfunction and mortality in acute respiratory distress syndrome patients treated with prone positioningThomas Weig, Silke Janitza, Michael Zoller, et al.
Infection|November 25, 2024
Importance of the neutrophil-to-lymphocyte ratio as a marker for microbiological specimens in critically ill patients after liver or lung transplantationSteffen B Wiegand, Michael Paal, Jette Jung, et al.
Der Anaesthesist|December 28, 2020
[Characteristics and outcome of 70 ventilated COVID-19 patients : Summary after the first wave at a university center]Ines Schroeder, Christina Scharf, Michael Zoller, et al.
Infectious Diseases and Therapy|August 18, 2024
Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb<sup>®</sup> in Patients with Hyperinflammation: A Prospective StudyHelen Graf, Caroline Gräfe, Mathias Bruegel, et al.
Transplantation|August 7, 2019
Letermovir for Difficult to Treat Cytomegalovirus Infection in Lung Transplant RecipientsTobias Veit, Dieter Munker, Teresa Kauke, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 12, 2021
Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational studyTobias Veit, Dieter Munker, Jürgen Barton, et al.
Critical Care (London, England)|October 24, 2017
Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational studyLisa Ehmann, Michael Zoller, Iris K Minichmayr, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 24, 2021
Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrationsSimon Kallee, Christina Scharf, Ines Schroeder, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Blood Purification|November 7, 2024
Albumin and Platelet Loss during the Application of CytoSorb® in Critically Ill Patients: A post hoc Analysis of the Cyto-SOLVE TrialClara Isabell Brozat, Michael Zoller, Sandra Frank, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2016
Predictors of Inadequate Linezolid Concentrations after Standard Dosing in Critically Ill PatientsMax Taubert, Michael Zoller, Barbara Maier, et al.
Journal of Critical Care|March 27, 2014
Influence of abdominal obesity on multiorgan dysfunction and mortality in acute respiratory distress syndrome patients treated with prone positioningThomas Weig, Silke Janitza, Michael Zoller, et al.
Infection|November 25, 2024
Importance of the neutrophil-to-lymphocyte ratio as a marker for microbiological specimens in critically ill patients after liver or lung transplantationSteffen B Wiegand, Michael Paal, Jette Jung, et al.
Der Anaesthesist|December 28, 2020
[Characteristics and outcome of 70 ventilated COVID-19 patients : Summary after the first wave at a university center]Ines Schroeder, Christina Scharf, Michael Zoller, et al.
Infectious Diseases and Therapy|August 18, 2024
Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb<sup>®</sup> in Patients with Hyperinflammation: A Prospective StudyHelen Graf, Caroline Gräfe, Mathias Bruegel, et al.
Transplantation|August 7, 2019
Letermovir for Difficult to Treat Cytomegalovirus Infection in Lung Transplant RecipientsTobias Veit, Dieter Munker, Teresa Kauke, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 12, 2021
Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational studyTobias Veit, Dieter Munker, Jürgen Barton, et al.
Critical Care (London, England)|October 24, 2017
Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational studyLisa Ehmann, Michael Zoller, Iris K Minichmayr, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 24, 2021
Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrationsSimon Kallee, Christina Scharf, Ines Schroeder, et al.
Pageof 9